Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer

Kosuke Mima, Takeo Fukagawa, Junji Kurashige, Yuki Takano, Ryutaro Uchi, Hiroki Ueo, Tae Matsumura, Masahisa Ishibashi, Genta Sawada, Yusuke Takahashi, Sayuri Akiyoshi, Hidetoshi Eguchi, Tomoya Sudo, Keishi Sugimachi, Masayuki Watanabe, Hideshi Ishii, Masaki Mori, Hideo Baba, Mitsuru Sasako, Koshi Mimori

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The prognosis for individuals that are diagnosed with gastric cancer remains poor due to the high frequency of metastatic disease. In response to tumor-derived secreted factors, the bone marrow generates a suitable microenvironment for the development of metastasis. However, it is largely unknown whether secreted factors in bone marrow associated with metastatic disease of patients with gastric cancer are present. Secreted factors from the bone marrow of patients with metastatic gastric cancer were identified using a DNA microarray analysis and the mRNA expression levels were investigated in 355 bone marrow, 295 peripheral blood and 144 primary site samples using quantitative PCR (qPCR). Using DNA microarray analysis, the present study identified bone morphogenetic protein 8B (BMP8B) as a secreted signaling molecule in the bone marrow that was associated with the metastatic disease of human gastric cancer. The expression levels of BMP8B in the bone marrow of 355 gastric cancer patients were increased with metastatic disease. A significant correlation was demonstrated between BMP8B mRNA expression in the bone marrow and in the peripheral blood. High BMP8B expression in the bone marrow was associated with the diffuse type of gastric cancer (P=0.009), lymph node metastasis (P=0.009), liver metastasis (P=0.044) and peritoneal dissemination (P<0.001). In the primary site, a multivariate analysis revealed BMP8B mRNA expression as one of the independent prognostic factors of gastric cancer [hazard ratio (HR), 2.066; 95% CI, 1.132-3.772]. This study suggests that BMP8B, a previously unknown secreted factor in cancer progression, has the potential to be used as a prognostic biomarker. The present study may provide insight into a new mechanism that underlies the dissemination of gastric cancer cells.

Original languageEnglish
Pages (from-to)387-392
Number of pages6
JournalOncology Letters
Volume6
Issue number2
DOIs
Publication statusPublished - Aug 1 2013

Fingerprint

Bone Morphogenetic Proteins
Stomach Neoplasms
Bone Marrow
Gene Expression
Bone and Bones
Proteins
Microarray Analysis
Neoplasm Metastasis
Oligonucleotide Array Sequence Analysis
Messenger RNA
Neoplasms
Multivariate Analysis
Biomarkers
Lymph Nodes
Polymerase Chain Reaction
Liver

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer. / Mima, Kosuke; Fukagawa, Takeo; Kurashige, Junji; Takano, Yuki; Uchi, Ryutaro; Ueo, Hiroki; Matsumura, Tae; Ishibashi, Masahisa; Sawada, Genta; Takahashi, Yusuke; Akiyoshi, Sayuri; Eguchi, Hidetoshi; Sudo, Tomoya; Sugimachi, Keishi; Watanabe, Masayuki; Ishii, Hideshi; Mori, Masaki; Baba, Hideo; Sasako, Mitsuru; Mimori, Koshi.

In: Oncology Letters, Vol. 6, No. 2, 01.08.2013, p. 387-392.

Research output: Contribution to journalArticle

Mima, K, Fukagawa, T, Kurashige, J, Takano, Y, Uchi, R, Ueo, H, Matsumura, T, Ishibashi, M, Sawada, G, Takahashi, Y, Akiyoshi, S, Eguchi, H, Sudo, T, Sugimachi, K, Watanabe, M, Ishii, H, Mori, M, Baba, H, Sasako, M & Mimori, K 2013, 'Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer', Oncology Letters, vol. 6, no. 2, pp. 387-392. https://doi.org/10.3892/ol.2013.1392
Mima, Kosuke ; Fukagawa, Takeo ; Kurashige, Junji ; Takano, Yuki ; Uchi, Ryutaro ; Ueo, Hiroki ; Matsumura, Tae ; Ishibashi, Masahisa ; Sawada, Genta ; Takahashi, Yusuke ; Akiyoshi, Sayuri ; Eguchi, Hidetoshi ; Sudo, Tomoya ; Sugimachi, Keishi ; Watanabe, Masayuki ; Ishii, Hideshi ; Mori, Masaki ; Baba, Hideo ; Sasako, Mitsuru ; Mimori, Koshi. / Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer. In: Oncology Letters. 2013 ; Vol. 6, No. 2. pp. 387-392.
@article{27e6fb221e6441d1a89488142ba9d4f0,
title = "Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer",
abstract = "The prognosis for individuals that are diagnosed with gastric cancer remains poor due to the high frequency of metastatic disease. In response to tumor-derived secreted factors, the bone marrow generates a suitable microenvironment for the development of metastasis. However, it is largely unknown whether secreted factors in bone marrow associated with metastatic disease of patients with gastric cancer are present. Secreted factors from the bone marrow of patients with metastatic gastric cancer were identified using a DNA microarray analysis and the mRNA expression levels were investigated in 355 bone marrow, 295 peripheral blood and 144 primary site samples using quantitative PCR (qPCR). Using DNA microarray analysis, the present study identified bone morphogenetic protein 8B (BMP8B) as a secreted signaling molecule in the bone marrow that was associated with the metastatic disease of human gastric cancer. The expression levels of BMP8B in the bone marrow of 355 gastric cancer patients were increased with metastatic disease. A significant correlation was demonstrated between BMP8B mRNA expression in the bone marrow and in the peripheral blood. High BMP8B expression in the bone marrow was associated with the diffuse type of gastric cancer (P=0.009), lymph node metastasis (P=0.009), liver metastasis (P=0.044) and peritoneal dissemination (P<0.001). In the primary site, a multivariate analysis revealed BMP8B mRNA expression as one of the independent prognostic factors of gastric cancer [hazard ratio (HR), 2.066; 95{\%} CI, 1.132-3.772]. This study suggests that BMP8B, a previously unknown secreted factor in cancer progression, has the potential to be used as a prognostic biomarker. The present study may provide insight into a new mechanism that underlies the dissemination of gastric cancer cells.",
author = "Kosuke Mima and Takeo Fukagawa and Junji Kurashige and Yuki Takano and Ryutaro Uchi and Hiroki Ueo and Tae Matsumura and Masahisa Ishibashi and Genta Sawada and Yusuke Takahashi and Sayuri Akiyoshi and Hidetoshi Eguchi and Tomoya Sudo and Keishi Sugimachi and Masayuki Watanabe and Hideshi Ishii and Masaki Mori and Hideo Baba and Mitsuru Sasako and Koshi Mimori",
year = "2013",
month = "8",
day = "1",
doi = "10.3892/ol.2013.1392",
language = "English",
volume = "6",
pages = "387--392",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer

AU - Mima, Kosuke

AU - Fukagawa, Takeo

AU - Kurashige, Junji

AU - Takano, Yuki

AU - Uchi, Ryutaro

AU - Ueo, Hiroki

AU - Matsumura, Tae

AU - Ishibashi, Masahisa

AU - Sawada, Genta

AU - Takahashi, Yusuke

AU - Akiyoshi, Sayuri

AU - Eguchi, Hidetoshi

AU - Sudo, Tomoya

AU - Sugimachi, Keishi

AU - Watanabe, Masayuki

AU - Ishii, Hideshi

AU - Mori, Masaki

AU - Baba, Hideo

AU - Sasako, Mitsuru

AU - Mimori, Koshi

PY - 2013/8/1

Y1 - 2013/8/1

N2 - The prognosis for individuals that are diagnosed with gastric cancer remains poor due to the high frequency of metastatic disease. In response to tumor-derived secreted factors, the bone marrow generates a suitable microenvironment for the development of metastasis. However, it is largely unknown whether secreted factors in bone marrow associated with metastatic disease of patients with gastric cancer are present. Secreted factors from the bone marrow of patients with metastatic gastric cancer were identified using a DNA microarray analysis and the mRNA expression levels were investigated in 355 bone marrow, 295 peripheral blood and 144 primary site samples using quantitative PCR (qPCR). Using DNA microarray analysis, the present study identified bone morphogenetic protein 8B (BMP8B) as a secreted signaling molecule in the bone marrow that was associated with the metastatic disease of human gastric cancer. The expression levels of BMP8B in the bone marrow of 355 gastric cancer patients were increased with metastatic disease. A significant correlation was demonstrated between BMP8B mRNA expression in the bone marrow and in the peripheral blood. High BMP8B expression in the bone marrow was associated with the diffuse type of gastric cancer (P=0.009), lymph node metastasis (P=0.009), liver metastasis (P=0.044) and peritoneal dissemination (P<0.001). In the primary site, a multivariate analysis revealed BMP8B mRNA expression as one of the independent prognostic factors of gastric cancer [hazard ratio (HR), 2.066; 95% CI, 1.132-3.772]. This study suggests that BMP8B, a previously unknown secreted factor in cancer progression, has the potential to be used as a prognostic biomarker. The present study may provide insight into a new mechanism that underlies the dissemination of gastric cancer cells.

AB - The prognosis for individuals that are diagnosed with gastric cancer remains poor due to the high frequency of metastatic disease. In response to tumor-derived secreted factors, the bone marrow generates a suitable microenvironment for the development of metastasis. However, it is largely unknown whether secreted factors in bone marrow associated with metastatic disease of patients with gastric cancer are present. Secreted factors from the bone marrow of patients with metastatic gastric cancer were identified using a DNA microarray analysis and the mRNA expression levels were investigated in 355 bone marrow, 295 peripheral blood and 144 primary site samples using quantitative PCR (qPCR). Using DNA microarray analysis, the present study identified bone morphogenetic protein 8B (BMP8B) as a secreted signaling molecule in the bone marrow that was associated with the metastatic disease of human gastric cancer. The expression levels of BMP8B in the bone marrow of 355 gastric cancer patients were increased with metastatic disease. A significant correlation was demonstrated between BMP8B mRNA expression in the bone marrow and in the peripheral blood. High BMP8B expression in the bone marrow was associated with the diffuse type of gastric cancer (P=0.009), lymph node metastasis (P=0.009), liver metastasis (P=0.044) and peritoneal dissemination (P<0.001). In the primary site, a multivariate analysis revealed BMP8B mRNA expression as one of the independent prognostic factors of gastric cancer [hazard ratio (HR), 2.066; 95% CI, 1.132-3.772]. This study suggests that BMP8B, a previously unknown secreted factor in cancer progression, has the potential to be used as a prognostic biomarker. The present study may provide insight into a new mechanism that underlies the dissemination of gastric cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=84879481993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879481993&partnerID=8YFLogxK

U2 - 10.3892/ol.2013.1392

DO - 10.3892/ol.2013.1392

M3 - Article

AN - SCOPUS:84879481993

VL - 6

SP - 387

EP - 392

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 2

ER -